Curtiland Deville

21PUBLICATIONS
75CO-AUTHORS
Radiation therapyPredictive and prognostic markersPharmacogenomicsInstruments and techniquesOrthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 19, 2026
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Dec 09, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.

Udit Singhal, Ralph Jiang, James A Proudfoot

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Nov 27, 2024
Health Disparities and Inequities in the Utilization of Proton Therapy for Prostate Cancer.

Cyrus Gavin Washington, Curtiland Deville

|Aug 10, 2024
In Silico Comparison of Three Different Beam Arrangements for Intensity-Modulated Proton Therapy for Postoperative Whole Pelvic Irradiation of Prostate Cancer.

Emile Gogineni, Hao Chen, Ian K Cruickshank

|Dec 20, 2023
Team Approach: Extremity Soft Tissue Sarcoma.

Carol D Morris, Lauren B Banks, Valerie A Fitzhugh

Pageof 4

Frequent Collaborators

4 joint publications

Matthew P Deek

4 joint publications

Channing J Paller

3 joint publications

Emile Gogineni

3 joint publications

Daniel E Spratt